KENGREAL 50MG/10ML L: payments to doctors
Payments that named KENGREAL 50MG/10ML L as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $51K
- Providers
- 1,310
- Transactions
- 2,312
- Average per transaction
- $22
The per-transaction average — $22 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,310 providers the average total is $39, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Chiesi USA, Inc. | $50,973 | 100.0% |